Table 1.
Clinical characteristics.
| Yes (N %) |
No (N %) |
p-Value | |
|---|---|---|---|
| (Total n = 124) | (Total n = 121) | ||
| Female (%) | 44 (35.5) | 60 (49.6) | 0.035 |
| Age (median [IQR]) | 58.00 [46.75, 73.25] | 55.00 [43.75, 65.00] | 0.037 |
| BMI (median [IQR]) | 27.40 [23.50, 31.85] | 27.75 [24.05, 33.60] | 0.433 |
| Systolic BP (median [IQR]) | 129.50 [115.00, 143.50] | 131.00 [117.75, 147.00] | 0.659 |
| Diastolic BP (median [IQR]) | 72.50 [61.00, 86.00] | 74.00 [64.75, 84.00] | 0.493 |
| Heart rate (mean (SD)) | 102.76 (21.13) | 102.90 (20.54) | 0.958 |
| Current smoker (%) | 4 (4.0) | 4 (3.6) | 1.000 |
| Race (%) | 0.067 | ||
| White | 40 (36.0) | 29 (26.1) | |
| Other | 46 (41.4) | 42 (37.8) | |
| Black or African American | 25 (22.5) | 40 (36.0) | |
| Comorbidities | |||
| CAD (%) | 48 (38.7) | 18 (15.0) | <0.001 |
| Hypertension (%) | 82 (66.1) | 66 (55.0) | 0.099 |
| Atrial Fibrillation (%) | 35 (28.2) | 6 (5.0) | <0.001 |
| COPD (%) | 11 (8.9) | 3 (2.5) | 0.062 |
| Asthma (%) | 12 (9.7) | 13 (10.8) | 0.931 |
| Diabetes mellitus (%) | 61 (49.2) | 47 (39.2) | 0.148 |
| Cancer (%) | 13 (10.5) | 12 (10.0) | 1.000 |
| Stroke (%) | 22 (17.7) | 7 (5.8) | 0.007 |
| Prior DVT or PE (%) | 48 (38.7) | 8 (6.7) | <0.001 |
| In-hospital treatments | |||
| Intravenous steroids (%) | 52 (41.9) | 29 (24.2) | 0.005 |
| Remdesivir (%) | 18 (14.5) | 10 (8.3) | 0.189 |
| Intravenous antibiotics (%) | 97 (78.2) | 57 (47.5) | <0.001 |
| Imaging characteristics | |||
| Contrast-enhanced (%) | 92 (74.2) | 101 (83.5) | 0.105 |
| PE diagnosed on imaging (%) | 17 (14.0) | 7 (5.8) | 0.053 |